Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients

scientific article published on 17 March 2012

Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00535-012-0569-0
P698PubMed publication ID22426637

P50authorKazuhiko KoikeQ21699620
Ryosuke TateishiQ37838027
Shinya MatsudaQ40486408
Hideo YasunagaQ40971030
P2093author name stringMasaya Sato
Haruhiko Yoshida
Hiromasa Horiguchi
P2860cites workPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldQ29614969
Management of hepatocellular carcinomaQ29616230
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalQ29616865
Cancer statistics, 2005Q29617572
Impact of hospital volume on postoperative complications and in-hospital mortality after renal surgery: data from the Japanese Diagnosis Procedure Combination DatabaseQ33572466
Current treatment for colorectal cancer metastatic to the liverQ33754893
Prevalence of malignant hyperthermia and relationship with anesthetics in Japan: data from the diagnosis procedure combination database.Q33775389
Multidisciplinary management of metastatic colorectal cancerQ33839174
Resection of hepatocellular carcinoma: a European experience on 328 cases.Q33958480
Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of JapanQ34091171
Surgeon volume and operative mortality in the United States.Q34279907
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added valueQ34290128
One Thousand Fifty-Six Hepatectomies Without Mortality in 8 YearsQ79278933
Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high riskQ80141796
Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastasesQ80213417
Liver resective surgery: a multivariate analysis of postoperative outcome and complicationQ80286919
Adverse effects of radiofrequency ablation of liver tumours in the NetherlandsQ81924482
Impact of hospital case volume on the quality of laparoscopic colectomy in JapanQ84187746
Perioperative risk assessment for hepatocellular carcinoma by using the MELD scoreQ84367911
Treatment of liver metastases from colorectal cancer: what is the best approach today?Q34351014
Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 casesQ34390771
Impact of hospital volume on operative mortality for major cancer surgeryQ34482407
Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injectionQ34503100
An analysis of 412 cases of hepatocellular carcinoma at a Western centerQ34503813
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantationQ34505935
Trends in long-term survival following liver resection for hepatic colorectal metastasesQ34523502
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.Q34581507
Treatment of liver metastases, an update on the possibilities and resultsQ34616010
Early hepatocellular carcinoma as an entity with a high rate of surgical cureQ34754443
Results of resections for hepatocellular carcinoma in a new hepatobiliary unitQ35048197
Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcomeQ35648684
Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in JapanQ40196680
Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single centerQ40518448
Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosisQ42633082
The effect of surgical volume and the provision of residency and fellowship training on complications of major hepatic resection.Q43709279
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.Q44135004
Hospital volume and surgical mortality in the United States.Q44464097
Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).Q45023757
Adverse events during radiofrequency treatment of 582 hepatic tumors.Q45078722
Arterial chemoembolization/embolization and early complications after hepatocellular carcinoma treatment: a safe standardized protocol in selected patients with Child class A and B cirrhosis.Q45982152
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complicationsQ46347660
Radiofrequency ablation of unresectable hepatic malignancies: lessons learnedQ46624740
Measles-related hospitalizations and complications in Japan, 2007-2008.Q47841319
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastasesQ49186620
Volume and process of care in high-risk cancer surgery.Q53256716
Chemoembolization in patients at high risk: results and complications.Q54064112
Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liverQ57001643
Severe Complications of Radiofrequency Ablation Therapy for Hepatocellular Carcinoma: An Analysis of 3,891 Ablations in 2,614 PatientsQ57763662
Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancerQ71380388
Influence of hospital procedure volume on outcomes following surgery for colon cancerQ73310903
Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastasesQ73876943
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patientsQ77983517
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decadeQ78341860
Indications and results of resection for hepatocellular carcinomaQ78513898
Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter studyQ78873230
P433issue10
P921main subjecthepatectomyQ1514021
patientQ181600
hepatocellular carcinomaQ1148337
P304page(s)1125-1133
P577publication date2012-03-17
P1433published inJournal of GastroenterologyQ15764399
P1476titleMortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients
P478volume47

Reverse relations

cites work (P2860)
Q91795303Alpha-fetoprotein is correlated with intrahepatic recurrence of hepatocellular carcinoma after a hepatectomy
Q41962614Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Q89302633Association between hospital volume and in-hospital mortality following radiofrequency ablation for hepatocellular carcinoma
Q40706736Clinical features and natural history of portal vein thrombosis after radiofrequency ablation for hepatocellular carcinoma in Japan
Q38723572Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resection
Q44379007Clinicopathology of recurrent hepatocellular carcinomas after radiofrequency ablation treated with salvage surgery
Q92534091Comparison of Microwave Ablation and Transarterial Chemoembolization for Single-Nodule Hepatocellular Carcinoma Smaller Than 5cm: A Propensity Score Matching Analysis
Q41496862Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching
Q89769440Complications after Radiofrequency Ablation for Hepatocellular Carcinoma: A Multicenter Study Involving 9,411 Japanese Patients
Q51495586Cost-Effective Surgical Management of Liver Disease Amidst a Financial Crisis.
Q33650840Defining incidence and risk factors of venous thromboemolism after hepatectomy.
Q93128876Effective prediction of postoperative complications for patients after open hepatectomy: a simplified scoring system based on perioperative parameters
Q36378778Effectiveness of impedance monitoring during radiofrequency ablation for predicting popping
Q64078084F-fludeoxyglucose positron emission tomography for diagnosis of HCC: implications for therapeutic strategy in curative and non-curative approaches
Q34513574Frequency of and predictive factors for vascular invasion after radiofrequency ablation for hepatocellular carcinoma.
Q36336198Function and clinical potential of microRNAs in hepatocellular carcinoma.
Q26738274Hepatocellular carcinoma in elderly patients: challenges and solutions
Q46624378High incidence of biliary stricture after associating liver partition and portal vein ligation for staged hepatectomy.
Q38507050Imaging of the postoperative liver: review of normal appearances and common complications
Q37693431Impact of hospital teaching status on length of stay and mortality among patients undergoing complex hepatopancreaticobiliary surgery in the USA.
Q40162339Incidence and Risk Factors for Postoperative Delirium in Patients After Hepatectomy
Q36709493Laparoscopic repair of diaphragm perforation with heart patch after microwave ablation
Q37735607Long-term outcomes of proton beam therapy in patients with previously untreated hepatocellular carcinoma.
Q87664325Management of hepatocellular carcinoma
Q26827161Management of hepatocellular carcinoma in the elderly
Q26822016Management of post-hepatectomy complications
Q36502706Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma
Q38925394Mortality and hemorrhagic complications associated with radiofrequency ablation for treatment of hepatocellular carcinoma in patients on hemodialysis for end-stage renal disease: a nationwide survey
Q36698026Patterns of prescribing radiotherapy and bevacizumab in nationwide practice - analysis of 101 designated cancer care hospitals in Japan
Q89570833Percutaneous treatment of IVC obstruction due to post-resection hepatic torsion associated with IVC thrombosis
Q44749754Predictors of intermediate-term survival with destination locoregional therapy of hepatocellular cancer in patients either ineligible or unwilling for liver transplantation
Q33818674Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study
Q52654017Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
Q51690868Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience.
Q41528463Randomized clinical trial of peritoneal lavage for preventing surgical site infection in elective liver surgery.
Q33816324Risk factors for pulmonary complications after hepatic resection: role of intraoperative hemodynamic instability and hepatic ischemia
Q89413813Risk factors of postoperative ascites on hepatic resection for hepatocellular carcinoma
Q50478924Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy.
Q39314901Systematic review of transarterial embolization for hepatocellular adenomas.
Q36314348Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma.
Q40808925The ADOPT-LC score: a novel predictive index of in-hospital mortality of cirrhotic patients following surgical procedures, based on a national survey
Q89262908The Outcome of Complex Hepato-Pancreato-Biliary Surgery for Elderly Patients: A Propensity Score Matching Analysis
Q37652110Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer
Q37249500Treatment for hepatocellular carcinoma in elderly patients: a literature review
Q39117225Using Dynamic 99mT c-GSA SPECT/CT fusion images for hepatectomy planning and postoperative liver failure prediction
Q35457125Verification of inferior right hepatic vein-conserving segments 7 to 8 resection of the liver

Search more.